News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
176,898 Results
Type
Article (32490)
Company Profile (16)
Press Release (144392)
Multimedia
Podcasts (5)
Webinars (9)
Section
Business (53509)
Career Advice (408)
Deals (3571)
Drug Delivery (9)
Drug Development (24383)
Employer Resources (37)
FDA (3494)
Job Trends (3352)
News (83231)
Policy (4580)
Tag
Academia (2414)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (20)
Alliances (11187)
ALS (29)
Alzheimer's disease (539)
Antibody-drug conjugate (ADC) (23)
Approvals (3512)
Artificial intelligence (56)
Autoimmune disease (1)
Automation (4)
Bankruptcy (27)
Best Places to Work (2747)
BIOSECURE Act (3)
Biosimilars (10)
Biotechnology (17)
Bladder cancer (24)
Brain cancer (9)
Breast cancer (88)
Cancer (643)
Cardiovascular disease (42)
Career advice (376)
Career pathing (9)
CAR-T (44)
Cell therapy (115)
Cervical cancer (6)
Clinical research (19062)
Collaboration (175)
Company closure (1)
Compensation (15)
Complete response letters (1)
COVID-19 (1187)
CRISPR (13)
C-suite (161)
Cystic fibrosis (23)
Data (801)
Decentralized trials (1)
Denatured (4)
Depression (6)
Diabetes (57)
Diagnostics (1682)
Diversity (5)
Diversity, equity & inclusion (14)
Drug discovery (23)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (21)
Earnings (7000)
Editorial (8)
Employer branding (3)
Employer resources (32)
Events (18243)
Executive appointments (476)
FDA (3757)
Frontotemporal dementia (4)
Funding (208)
Gene editing (36)
Generative AI (4)
Gene therapy (81)
GLP-1 (132)
Government (1001)
Guidances (8)
Healthcare (5173)
Huntington's disease (2)
IgA nephropathy (8)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1223)
Inflammatory bowel disease (44)
Inflation Reduction Act (2)
Influenza (17)
Intellectual property (22)
Interviews (46)
IPO (1563)
IRA (6)
Job creations (669)
Job search strategy (349)
Kidney cancer (5)
Labor market (9)
Layoffs (53)
Leadership (2)
Legal (823)
Liver cancer (21)
Lung cancer (84)
Lymphoma (48)
Machine learning (2)
Management (10)
Manufacturing (43)
MASH (28)
Medical device (3187)
Medtech (3188)
Mergers & acquisitions (2054)
Metabolic disorders (128)
Multiple sclerosis (20)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (2)
Neuroscience (676)
NextGen: Class of 2025 (1865)
Non-profit (1745)
Now hiring (4)
Obesity (42)
Opinion (41)
Ovarian cancer (33)
Pain (17)
Pancreatic cancer (30)
Parkinson's disease (41)
Partnered (4)
Patents (43)
Patient recruitment (35)
Peanut (12)
People (32696)
Pharmaceutical (1)
Phase I (5986)
Phase II (8697)
Phase III (5870)
Pipeline (219)
Policy (30)
Postmarket research (988)
Preclinical (3086)
Press Release (25)
Prostate cancer (28)
Psychedelics (9)
Radiopharmaceuticals (66)
Rare diseases (93)
Real estate (1343)
Recruiting (17)
Regulatory (3218)
Reports (6)
Research institute (1362)
Resumes & cover letters (27)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (11)
Series A (30)
Series B (19)
Sickle cell disease (17)
Special edition (1)
Spinal muscular atrophy (40)
Sponsored (6)
Startups (1131)
Stomach cancer (1)
Supply chain (1)
Tariffs (5)
The Weekly (1)
Vaccines (212)
Venture capitalists (2)
Weight loss (23)
Women's health (8)
Worklife (2)
Date
Today (39)
Last 7 days (178)
Last 30 days (657)
Last 365 days (7152)
2025 (2480)
2024 (7691)
2023 (9466)
2022 (11838)
2021 (13550)
2020 (13176)
2019 (12595)
2018 (9332)
2017 (8881)
2016 (9137)
2015 (10542)
2014 (8092)
2013 (7806)
2012 (7809)
2011 (7766)
2010 (7009)
Location
Africa (281)
Alabama (11)
Alaska (3)
Arizona (39)
Arkansas (6)
Asia (10648)
Australia (2647)
California (1434)
Canada (437)
China (106)
Colorado (60)
Connecticut (67)
Delaware (30)
Europe (28324)
Florida (165)
Georgia (51)
Idaho (12)
Illinois (143)
India (3)
Indiana (64)
Iowa (2)
Japan (57)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (154)
Massachusetts (929)
Michigan (43)
Minnesota (71)
Mississippi (1)
Missouri (22)
Montana (6)
Nebraska (4)
Nevada (14)
New Hampshire (9)
New Jersey (397)
New Mexico (8)
New York (409)
North Carolina (278)
North Dakota (2)
Northern California (700)
Ohio (70)
Oklahoma (5)
Oregon (9)
Pennsylvania (283)
Puerto Rico (1)
Rhode Island (12)
South America (312)
South Carolina (3)
Southern California (517)
Tennessee (25)
Texas (218)
United States (5169)
Utah (46)
Virginia (36)
Washington D.C. (18)
Washington State (142)
West Virginia (1)
Wisconsin (11)
176,898 Results for "wake forest university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
Biotech Leaders Implore Sen. Cassidy To Step Up in Wake of FDA Cuts
Biotech companies are already seeing regulatory delays and plenty of uncertainty after around 3,500 FDA employees were cut by the Trump administration.
April 10, 2025
·
3 min read
·
Annalee Armstrong
Editorial
In Wake of Elevidys Death, Duchenne Patient Community Vows to Push On
After Sarepta reported the death of a patient who had recently taken the gene therapy Elevidys, patient advocacy group Parent Project Muscular Dystrophy stepped up—as they always do.
March 20, 2025
·
3 min read
·
Annalee Armstrong
Business
Fauna Bio Announces Dr. Lara Do Amaral-Silva as Recipient of the CEPS FaunaBio Translational Research Award
Fauna Bio announced today Dr. Lara Do Amaral-Silva, assistant professor of biology at Wake Forest University, as the recipient of the FaunaBio Translational Research Award through the American Physiological Society (APS).
March 4, 2024
·
3 min read
Biotech Beach
Thermo Fisher Scientific Announces Latest Round of Oncomine Clinical Research Grant Awardees
Today, Thermo Fisher Scientific announced the latest recipients of the Oncomine Clinical Research Grant, recognizing research from the Melanoma Institute Australia, the University of Turin in Italy and Atrium Health Wake Forest Baptist Medical Center.
February 20, 2024
·
5 min read
Regulatory
Former FDA Officials Sound Alarm: Visible Changes May Be ‘Tip of the Iceberg’
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER director spoke to analysts about potential implications for drug review timelines and agency morale.
April 16, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs
February 25, 2025
·
19 min read
Biotech Beach
Convergent Research Announces Major New Funding Commitment to Forest Neurotech
Convergent Research today announced a new $14 million funding commitment from former Google CEO Eric Schmidt to Forest Neurotech, an initiative designed to create next-generation brain-computer-interfaces (BCIs) for individuals with neurological injuries or diseases.
March 11, 2024
·
2 min read
Biotech Bay
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM.
January 25, 2024
·
10 min read
Biotech Bay
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics, Incorporated announced additional 48-week data from FOREST-HCM, the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy, at the 73rd Annual American College of Cardiology Scientific Session taking place from April 6, 2024 –April 8, 2024 in Atlanta, GA.
April 5, 2024
·
10 min read
Biotech Bay
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced additional 48-week data from FOREST-HCM the open label extension clinical study of aficamten in patients with hypertrophic cardiomyopathy (HCM), at the 73rd Annual American College of Cardiology (ACC) Scientific Session taking place from April 6, 2024 –April 8, 2024.
April 5, 2024
·
10 min read
1 of 17,690
Next
